Loading organizations...
Loading organizations...
Pharmaceutical company specializing in iPSCs and neural differentiation.
Hopstem has raised $40.0M across 1 funding round.
Hopstem has raised $40.0M in total across 1 funding round.
Hopstem has raised $40.0M in total across 1 funding round.
Hopstem's investors include Lilly Asia Ventures.
Hopstem has raised $40.0M across 1 funding round. Most recently, it raised $40.0M Series B in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2021 | $40.0M Series B | Lilly Asia Ventures |